Ransom Advisory’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$330 Sell
46
-2,100
-98% -$16.6K ﹤0.01% 424
2025
Q3
$22.9K Hold
2,146
0.01% 216
2025
Q2
$20.8K Sell
2,146
-20
-0.9% -$206 0.01% 233
2025
Q1
$32.3K Hold
2,166
0.02% 218
2024
Q4
$32.3K Hold
2,166
0.01% 258
2024
Q3
$41.4K Hold
2,166
0.02% 236
2024
Q2
$44.8K Hold
2,166
0.02% 222
2024
Q1
$40.7K Buy
+2,166
New +$37.2K 0.02% 199

Other funds holding OGN

Ransom Advisory's OGN Position: Q4 2025 in Review

Ransom Advisory reduced its Organon & Co (OGN) stake by 98% in Q4 2025, selling an estimated $16.6K and leaving 46 shares worth $330. The position accounts for ﹤0.01% of the portfolio, ranked #424.

Ransom Advisory first reported a position in OGN in Q1 2024 and has held it in 8 quarters since. The position peaked at $44.8K in Q2 2024. 632 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Ransom Advisory held 46 shares of Organon & Co worth $330 as of Q4 2025.
  • Ransom Advisory sold 2,100 Organon & Co shares in Q4 2025, an estimated $16.6K.
  • Organon & Co made up ﹤0.01% of Ransom Advisory's portfolio in Q4 2025, its #424 holding.
  • Ransom Advisory first reported a position in Organon & Co in Q1 2024 and has held it in 8 quarters since.
  • Ransom Advisory's Organon & Co position peaked at $44.8K in Q2 2024.
  • 632 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.